1. Home
  2. GABC vs NVAX Comparison

GABC vs NVAX Comparison

Compare GABC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo German American Bancorp Inc.

GABC

German American Bancorp Inc.

N/A

Current Price

$39.24

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$10.42

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GABC
NVAX
Founded
1910
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
GABC
NVAX
Price
$39.24
$10.42
Analyst Decision
Hold
Hold
Analyst Count
2
9
Target Price
$46.50
$11.33
AVG Volume (30 Days)
87.5K
4.3M
Earning Date
04-27-2026
05-20-2026
Dividend Yield
3.09%
N/A
EPS Growth
8.13
309.76
EPS
3.06
2.58
Revenue
$487,401,000.00
$1,123,479,000.00
Revenue This Year
$17.03
N/A
Revenue Next Year
$3.92
N/A
P/E Ratio
$13.08
$3.85
Revenue Growth
37.80
64.69
52 Week Low
$32.75
$5.01
52 Week High
$45.00
$11.85

Technical Indicators

Market Signals
Indicator
GABC
NVAX
Relative Strength Index (RSI) 32.96 60.60
Support Level $37.28 $6.34
Resistance Level $39.95 $10.42
Average True Range (ATR) 1.03 0.71
MACD -0.43 0.03
Stochastic Oscillator 10.57 56.02

Price Performance

Historical Comparison
GABC
NVAX

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: